Early research (Phase 1)UnknownNCT03747744
What this trial is testing
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)
Who this might be right for
Melanoma
Universitair Ziekenhuis Brussel 18